A New Treatment Delivering Uncommon Results

OA is a degenerative joint condition that impacts millions of people around the world. While the condition can develop in any joint in the body, it most commonly impacts the knees, hips, neck, lower back, and small joints of the fingers and toes, and causes reduced mobility and debilitating pain.

This condition begins when the cartilage at the end of the patient’s impacted bones begins to wear down. In healthy bones, this cartilage acts as a “cap” on the joint bones that allows their smooth, pain-free motion. When a patient suffers from OA, this cartilage progressively breaks down, leading to pain, swelling, and reduced mobility. If the patient’s condition continues to progress, they may:

• Grow painful bone spurs
• Experience a grating sensation
• Chip bones and cartilage into the joint
• Trigger inflammation that damages the cartilage further
• Lose all of their cartilage, and develop significant joint damage over time

As the condition progresses, the patient often loses mobility, and experiences an overall decreased quality of life filled with constant pain, sleepless nights, and an inability to perform basic day-to-day movements they once took for granted.

In short: OA is a debilitating degenerative disorder that can only be effectively treated by reducing the bones’ accumulated damage, regenerating lost cartilage, and restoring the healthy structure and functioning of the joint.

Unfortunately, conventional therapies are not able to address these underlying elements of AO and at best can mask its symptoms in the short-term.